Lenalidomide oral monotherapy produces durable responses in relapsed or refractory indolent non-Hodgkin's Lymphoma.
暂无分享,去创建一个
J. Vose | K. Takeshita | C. Reeder | T. Witzig | J. Zeldis | P. Wiernik | A. Ervin‐Haynes | T. Moore | D. Pietronigro | G. Justice | M. Voralia | C. Cole | H. Kaplan